
Crohn's disease Program in Pharmaceutical Benefits Scheme (PBS) 012-18051111

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

This document outlines details of PBS-subsidised biological agents for
patients with Crohn's disease (CD) and fistulising Crohn's disease
(FCD).

Crohn's disease and listing dates

Crohn’s disease is an immune condition affecting the gastrointestinal
tract.

Listing dates are:

-   infliximab - 1 October 2007
-   adalimumab - 1 August 2008
-   vedolizumab - 1 August 2015
-   ustekinumab - 1 September 2017

An adult patient who received PBS-subsidised treatment with a biological
medicine prior to 1 September 2017 is considered to have started their
treatment cycle as of 1 September 2017.

A paediatric patient who received PBS-subsidised biological medicine
treatment prior to 1 August 2015 is considered to have started their
treatment cycle as of 1 August 2015.

For further information, see Written Authority Required Drugs.

Fistulising Crohn's disease and listing dates

Fistulising Crohn’s disease is a similar condition to Crohn’s disease
affecting the gastrointestinal tract.

Listing dates are:

-   infliximab - 1 August 2010
-   adalimumab - 1 April 2011

A patient who received PBS-subsidised adalimumab or infliximab treatment
prior to 1 April 2011 is considered to have started their treatment
cycle as of 1 April 2011.

For more information, see Written Authority Required Drugs.

Enquiries

Transfer enquiries about prescription arrangements to the PBS Complex
Drugs Programs team and choose the option relevant to the condition
treated.

The Resources page contains links to application forms, calculation
sheets, contact details, item and restriction codes, FAQs, the PBS
schedule and the Services Australia website.

Related links

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA
System)

Process telephone Authority approval application

Processing and National Demand Allocation (PaNDA)

Processing written authority approval requests

Processing Written Authority Required Listings

Written Authority required drugs

                                   

-   Services Australia ABN 90 794 605 008 
